GOLDMAN SACHS GROUP INC - IMMUNIC INC ownership

IMMUNIC INC's ticker is IMUX and the CUSIP is 4525EP101. A total of 66 filers reported holding IMMUNIC INC in Q2 2023. The put-call ratio across all filers is 1.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of IMMUNIC INC
ValueSharesWeighting
Q1 2024$18,234
-63.5%
13,814
-58.9%
0.00%
Q1 2023$50,021
+111057.8%
33,571
+135.4%
0.00%
Q3 2022$45
-51.6%
14,263
-47.0%
0.00%
Q2 2022$93
-100.0%
26,891
-89.1%
0.00%
-100.0%
Q1 2022$2,781,000
+64.9%
246,121
+39.7%
0.00%
Q4 2021$1,686,000
+13.5%
176,118
+4.9%
0.00%
Q3 2021$1,485,000
+896.6%
167,877
+1283.9%
0.00%
Q2 2021$149,000
-57.2%
12,131
-46.7%
0.00%
Q4 2020$348,000
-13.4%
22,741
+4.9%
0.00%
Q3 2020$402,00021,6690.00%
Other shareholders
IMMUNIC INC shareholders Q2 2023
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 1,104,241$3,832,0003.26%
Omega Fund Management, LLC 1,788,160$6,205,0001.98%
Parkman Healthcare Partners LLC 650,028$2,256,0000.83%
COMMODORE CAPITAL LP 893,013$3,099,0000.66%
Otter Creek Advisors, LLC 239,200$830,0000.56%
COWEN AND COMPANY, LLC 1,200,691$4,166,0000.40%
KCK LTD. 69,704$242,0000.34%
RTW INVESTMENTS, LP 2,761,968$9,584,0000.25%
Artal Group S.A. 700,000$2,429,0000.13%
Soleus Capital Management, L.P. 240,000$833,0000.13%
View complete list of IMMUNIC INC shareholders